Abstract
Rapamycin in preventive (very low) doses.
Highlights
In the recent paper of Popovich et al published in Cancer Biology and Therapy [1], positive effects of low doses of rapamycin on survival of caner-prone HER2/neu mice have been reported
This study helps to further separate the lifeextending effect of rapamycin from its cancerpreventing properties. These findings indicate that rapamycin can be considered as a good candidate for a preventive anti-aging medicine
Using a substance as a preventive medicine immediately raises questions about its overall safety and potential side effects; these questions are even more principle here compared with the situation of disease treatment
Summary
In the recent paper of Popovich et al published in Cancer Biology and Therapy [1], positive effects of low doses of rapamycin on survival of caner-prone HER2/neu mice have been reported. This study helps to further separate the lifeextending effect of rapamycin from its cancerpreventing properties. These findings indicate that rapamycin can be considered as a good candidate for a preventive anti-aging medicine.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
